Skip to content

Clinical trials

Phase 1/2 Neoplasms trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 1/2 Country / region: Czechia Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20151
20171
20182
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Active, not recruiting1
Completed1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
AstraZeneca1
Bayer1
Curis, Inc.1
Hamlet Pharma AB1
Revolution Medicines, Inc.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms8
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Hematologic Neoplasms1
Immune System Diseases1
Immunoproliferative Disorders1
Lung Neoplasms1
Lymphatic Diseases1
Lymphoma1
Lymphoma, Non-Hodgkin1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.